News

March 28, 2018

NEW RELEASE: GEFIT

Targeted therapy for locally advanced or metastatic non-small-cell lung cancer

MORE

March 26, 2018

Emulimod

Prescribed for the treatment of patients suffering from recurrent (or relapsing) multiple sclerosis (MS).

MORE

March 26, 2018

CABAZIL®

For the treatment of patients suffering from metastatic prostate cancer

MORE

February 27, 2018

Presenting our new corporate website

MORE

January 27, 2018

Presenting Dacarbazina

The only dacarbazine product available in the market.

MORE

September 28, 2017

New Clinical Evidence

KYPROLIS ® Significantly improves overall survival in patients with relapsed multiple myeloma.

MORE

July 26, 2017

Launches:

Amgen has entrusted us with the representation of two new licences: Neupogen (filgrastim) and Neulastim (pegfilgrastim).

MORE

May 22, 2017

Launching Celixafor

We are pleassed to inform you about the incorporation of Celixafor®, Plerixafor 20 mg/ml 1 ampoule, to our hematology Vademecum.

MORE

May 22, 2017

Invitation Stand ASCO 8112

Between the 2 to 6 of June, we will be part again of the world's biggest oncology congress: ASCO.

MORE

February 20, 2017

Nuwiq

The First human recombinant factor VIII oh human cell

MORE